Bio-Techne opens Bristol GMP facility to expand cell therapy supply network

TECH•2026-10-08

Bio-Techne opened an operational, 10,000-square-foot GMP small-molecule manufacturing facility in Bristol, UK, with five ISO-8 cleanrooms and two ISO-7 cleanrooms.

1. Bristol facility opens

The facility is producing GMP-grade small molecules for cell therapy developers globally. The Bristol site extends Bio-Techne’s GMP network alongside its operations in St. Paul, Minnesota, supporting customers from development through commercial manufacturing.

Bio-Techne opens Bristol GMP facility to expand cell therapy supply network

1. Bristol facility opens

Related News

GlobalFoundries gains after $2 billion silicon interposer deal with TSMC

Nucor invests $105 million to expand Indiana utility towers and structures plant

Pacira BioSciences jumps on $1.65 billion Viatris buyout deal

Diebold Nixdorf partners with stc pay Bahrain to roll out DN Series cash recyclers network

Firefly Aerospace's Scitec announces extension to CBC2 contract with U.S. Air Force